Business
Bio Spectrum
Gaudium IVF and Women Health re-files DRHP with SEBI
Delhi-based Gaudium IVF and Women Health has refiled its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI).
1 min |
November 2025
Bio Spectrum
Ayush Ministry launches Integrative Oncology Research and Care Centre
The Ministry of Ayush inaugurated the Integrative Oncology Research and Care Centre (IORCC) at the All India Institute of Ayurveda (AIIA), Dhargal, Goa.
1 min |
November 2025
Bio Spectrum
Medtronic unveils two advanced surgical energy generators in India
Medtronic, a global leader in healthcare technology, has announced the launch of two advanced surgical energy generators in India under the Valleylab FT10 series - the Valleylab FT10 Electrosurgical Generator (VLFT10FXGEN) and the Valleylab FT10 Vessel Sealing Generator (VLFT10LSGEN).
1 min |
November 2025
Bio Spectrum
Cabinet approves DSIR Scheme of Capacity Building and HR Development with outlay of Rs 2277 Cr
The Cabinet, chaired by the Prime Minister Narendra Modi, has approved the Department of Scientific and Industrial Research Council of Scientific and Industrial Research (DSIR/CSIR) Scheme on \"Capacity Building and Human Resource (HR) Development\" with a total outlay of Rs 2277.397 crore for the period of the Fifteenth Finance Commission Cycle 2021-22 to 2025-26.
1 min |
November 2025
Bio Spectrum
Atal Innovation Mission's Frontier Region Programme paves way for 500 new Atal Tinkering Labs in J&K
In line with Prime Minister Narendra Modi's vision of building a Viksit Bharat by 2047, the Atal Innovation Mission (AIM), NITI Aayog, Government of India, in collaboration with the University of Kashmir, has launched the Atal Tinkering Labs (ATL) Sarthi and Frontier Region Programme at the Convocation Complex, University of Kashmir.
1 min |
November 2025
Bio Spectrum
Rethinking Accountability in Clinical Research: Building a Culture of Ethical Confidence
India's CROs are growing fast; sustaining trust requires strong ethics, transparency, and collaboration. Ethical integrity will be India's key differentiator and global advantage.
2 min |
November 2025
Bio Spectrum
‘Our API sector can remain competitive and play a critical role in the global supply chain”
With over 35 years of expertise in manufacturing bulk drugs and APIs, A P Rameswara Rao, has recently taken charge as the National President of Bulk Drugs Manufacturers Association of India (BDMAI). In an interaction with BioSpectrum India Rao talks about strengthening India's self-reliance in APIs and reducing import dependency, promoting global quality standards and compliance across the industry, advocating policy reforms with government and regulatory bodies and supporting sustainable growth through innovation, R&D, and environmental responsibility. Edited excerpts:
2 min |
November 2025
Bio Spectrum
Lupin strengthens global specialty ophthalmology biz with acquisition of VISUfarma
Mumbai-based pharma major Lupin Limited has announced that its wholly owned subsidiary, Nanomi B.V., has signed a definitive agreement for the acquisition of VISUfarma B.V., a portfolio company of global healthcare specialist investor GHO Capital Partners LLP.
1 min |
November 2025
Bio Spectrum
"Absence of specific safety standards for printing inks used in pharma packaging is a critical issue
Siegwerk, a German leader in printing inks and coatings for packaging applications and labels, with annual Indian revenue of over Rs 1000 crore, has recently announced an investment of Rs 350 crore over the next three years to expand its operations in India. Further, the firm is making a foray into the pharmaceutical market in India with mineral oil-free inks, designed specifically to reduce health risks associated with ink migration in medicine packaging. In an exclusive conversation with BioSpectrum, Jatin Takkar, Head, Product Safety & Regulatory, Siegwerk India, talks about how these inks are making pharma packaging safer, and about the company's growth plans in this space. Edited excerpts:
4 min |
November 2025
Bio Spectrum
New York State Emerges as a Global Biopharma Manufacturing Hub: Lessons from Garonit Pharma's Expansion
Changing Trade Landscape Signals a New Chapter in India-U.S. Pharma Ties
3 min |
November 2025
Bio Spectrum
Somerset Indus Capital Partners exits from Apex Hospitals, delivering 4x return
Somerset Indus Capital Partners has announced its full exit from Apex Hospitals, a leading multispecialty hospital group in Rajasthan renowned for advancing high-quality healthcare in the region.
1 min |
November 2025
Bio Spectrum
India announces formation of Veterinary Vaccine India Manufacturers Association
In a significant development for India's animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA). VVIMA is a nongovernment, not-for-profit organisation that will serve as the collective voice of India's veterinary vaccine manufacturers.
1 min |
November 2025
Bio Spectrum
What will the export scenario be by 2030?
Indian diagnostic manufacturers export widely today - depending on the size of the Indian IVD company, most Indian players ship to anywhere between 40 and 100 countries worldwide, spanning Asia, Africa, the Middle East, Latin America, and more.
5 min |
November 2025
Bio Spectrum
Ministry of Ayush to co-host 2nd Global Summit on Traditional Medicine with WHO
The Ministry of Ayush, Government of India has signed an agreement with the World Health Organization (WHO) to co-host the 2nd WHO Global Summit on Traditional Medicine on the theme “Restoring balance for people and planet: The science and practice of well-being”.
1 min |
November 2025
Bio Spectrum
"When domestic and global players stand together, it strengthens the entire diagnostics ecosystem"
The Association of Diagnostics Manufacturers of India (ADMI), the apex body representing the country's in vitro diagnostics (IVD) industry, has announced the election of Jatin Mahajan, Managing Director of J. Mitra & Co., as its new President recently. In an interaction with BioSpectrum India Mahajan explains how ADMI can create inclusive working groups and open forums within the association, allowing MNCs and Indian firms to share perspectives and align on goals. Edited excerpts:
7 min |
November 2025
Bio Spectrum
Keeping Watchful Eye on US Pharma Tariffs
The axe has finally fallen — though not as harshly as feared, at least for the Indian pharmaceutical industry. The United States has dropped a bombshell on the global drug trade, with President Donald Trump announcing a 100 per cent tariff on imports of branded or patented pharmaceutical products effective October 1, 2025.
2 min |
November 2025
Bio Spectrum
‘Minicircle DNA will become a cornerstone of modern gene and cell therapy"
PlasmidFactory GmbH, based in Bielefeld, Germany, is recognised as a leading CDMO for the production of plasmid and Minicircle DNA. Over the past 25 years, the company has evolved from a small academic spin-off into a global reference for DNA manufacturing in gene and cell therapy. Following the launch of its new GMP facility and the clinical success of several Minicircle-based therapies, PlasmidFactory is entering a new phase—expanding its impact from plasmid DNA manufacturing toward next-generation, virus-free gene delivery. In an interation with BioSpectrum India Dr Ram Shankar, Chief Scientific Officer at PlasmidFactory, shares his insights into the company’s latest developments and the growing importance of Minicircle technology in cell and gene therapy. Editd excerpts;
5 min |
November 2025
Bio Spectrum
Cabinet gives nod to Phase III of Biomedical Research Career Programme
The Union Cabinet chaired by the Prime Minister Narendra Modi has approved the continuation of the Biomedical Research Career Programme (BRCP), Phase III.
1 min |
November 2025
Bio Spectrum
India's Pharma Reforms Target Global Credibility
The Indian government has introduced several measures to simplify drug approvals and support innovation.
9 min |
October 2025
Bio Spectrum
How Waste Management Strategies Can Transform Indian Pharma Manufacturing
Sustainability will be a key success factor as India's pharmaceutical industry enters its next stage of expansion.
7 min |
October 2025
Bio Spectrum
IASST synthesises new compound to combat aggressive breast cancer
A newly designed nitro-substituted organoselenium compound by Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology (DST), can reduce the invasiveness of aggressive triplenegative breast cancer cells by modulating various Se Se signalling pathways.
1 min |
October 2025
Bio Spectrum
DPIIT signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Pfizer Limited.
1 min |
October 2025
Bio Spectrum
WHO unveils updated guideline on HIV service delivery
WHO has released an updated guideline to support integrated HIV service delivery, promote long-term adherence to antiretroviral therapy (ART), and improve the overall health and well-being of people living with HIV.
1 min |
October 2025
Bio Spectrum
Scientists in Kolkata explore therapeutic potential of accessory proteins
A hidden protein that protects our cells from mechanical stress could provide a new direction to therapeutic strategies for diseases where protein stability under force is compromised like heart muscle disease or genetic disorders called laminopathies.
1 min |
October 2025
Bio Spectrum
US FDA advances rare disease drug development
The US Food and Drug Administration (FDA) has introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.
1 min |
October 2025
Bio Spectrum
WHO updates list of essential medicines to include key cancer, diabetes treatments
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLC), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.
1 min |
October 2025
Bio Spectrum
Agilent's MMR IHC Panel pharmDx (Dako Omnis) receives European IVDR Certification
Agilent Technologies Inc. has announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer.
1 min |
October 2025
Bio Spectrum
Aodh Lifesciences gets support from TDB to redefine pneumonia treatment
The Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to Aodh Lifesciences, a startup based in Hyderabad, for development of Indigenous Antibiotic Nebulisation Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).
1 min |
October 2025
Bio Spectrum
Antara Senior Care names Mukesh Ghuraiya as Chief Marketing Officer
Antara Senior Care, a fully integrated senior care ecosystem, has appointed Mukesh Ghuraiya as the Executive Vice-President and Chief Marketing Officer (CMO).
1 min |
October 2025
Bio Spectrum
Poly Medicure acquires PendraCare Group for Rs 188.5 Cr
Poly Medicure, a Delhi-based medical device company, has announced signing of definitive agreements to acquire 90 per cent stake in PendraCare Group consisting of PendraCare Holdings and Welling Medical from Welling Holdings B.V. at an Enterprise value of Rs 188.5 crore (Euro 18.3 million).
1 min |